Up 43% in a year, Allkem share price dips despite record annual lithium production at Olaroz

The Allkem share price has been a very strong performer in 2023, up 43% since the opening bell on 3 January.

| More on:
Two miners standing together.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Allkem Ltd (ASX: AKE) share price is down 0.6%.

The S&P/ASX 200 Index (ASX: XJO) lithium stock closed yesterday trading for $15.79. In morning trade today shares are swapping hands for $15.69 apiece.

This comes following the release of Allkem's quarterly activity results for the three months ending 30 June.

Read on for the highlights.

Allkem share price dips despite strong cash generation

  • Quarterly revenue of approximately US$334 million
  • Gross operating cash margin of approximately US$274 million (82%)
  • Spodumene sales of 46,787 dry metric tonnes (dmt) at an average sales price of US$4,297 /dmt CIF for SC 5.3%
  • Net cash of US$648 million as at 30 June, up US$71 million from 31 March
  • Net cash generated from operations and corporate of US$220 million

What else happened during the quarter?

The Allkem share price is in the red in early trade today despite the lithium miner reporting record annual production out of its Olaroz Lithium Facility. Olaroz produced 16,703 tonnes of lithium carbonate with a record 5,059 tonnes produced in the June quarter. That's up 47% from the previous corresponding period (pcp).

Lithium carbonate sales of 3,430 tonnes generated Olaroz quarterly revenue of around US$132 million, with a gross cash margin of 85%. Excluding shipments to Naraha, Allkem reported its third party lithium carbonate sales averaged US$38,062/tonne free on board (FOB) over the quarter.

Some strong reported results at Mt Cattlin also aren't lifting the Allkem share price today.

According to the release, Mt Cattlin produced 130,984 tonnes of spodumene concentrate over the full year, exceeding guidance. 58,059 dmt at 5.3% Li2O grade was produced during the quarter, a 50% increase from the March quarter.

And Mt Cattlin's Ore Reserve update confirmed an additional four to five year mine life via open pit methods.

In another quarterly highlight, Allkem and Livent announced a definitive agreement to "combine in an all-stock merger of equals to create a leading global integrated lithium chemicals producer".

And Allkem signed a US$130 million sustainability-linked green project financing facility with the International Finance Corporation for its Sal de Vida Stage 1 project.

Allkem share price snapshot

The Allkem share price has been a very strong performer in 2023, up 43% since the opening bell on 3 January.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.
Earnings Results

Beach Energy H1 FY26 earnings: Profit drops as costs rise and volumes slip

Beach Energy shares drop focus as H1 FY26 profit falls 32%, driven by lower prices, higher costs and reduced production.

Read more »

An older woman gazes over the top of her glasses with a quizzical expression as if she is considering some information.
Earnings Results

What can investors expect from ResMed, Cochlear and CSL shares this reporting season?

Here's updated analysis on three of Australia's largest healthcare stocks.

Read more »

Image of a shopping centre.
Earnings Results

Are these ASX REITs a buy, hold or sell this earnings season?

Here's what brokers are saying about these REITs

Read more »

Six smiling health workers pose for a selfie.
Earnings Results

Why this ASX healthcare stock is a speculative buy

This ASX healthcare stock has plenty of upside according to Bell Potter.

Read more »

Magnifying glass in front of an open newspaper with paper houses.
Earnings Results

Why these 2 ASX REITs are in the red after today's results

These 2 ASX REIT shares fall as their half-year results fail to impress investors.

Read more »

A young man stands facing the camera and scratching his head with the other hand held upwards wondering if he should buy Whitehaven Coal shares
Earnings Results

ASX 300 stock tumbles despite 22% profit jump

Here's what this lottery stock reported today.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Earnings Results

Guess which ASX 200 stock is jumping 8% on results day

Let's see what this company reported for the first half.

Read more »

A young man clasps his hand to his head with a pained expression on his face and a laptop in front of him.
Earnings Results

Credit Corp share price crashes 14% following H1 FY26 result

The debt collector posted its results for the first half of FY26 this morning.

Read more »